J Zeif

Queen Elizabeth Hospital Birmingham

Papers

1

Total Citations

9

H-Index

1

About

Dr. J. Zeif has made foundational contributions to urologic oncology, particularly in refining surgical outcomes for prostate cancer. His landmark work, “Ultrasensitive Prostate Specific Antigen Assay Following Laparoscopic Radical Prostatectomy – An Outcome Measure for Defining the Learning Curve” (2009, 9 citations), introduced a novel methodology for objectively assessing surgical proficiency. By leveraging ultrasensitive PSA assays to detect residual disease after laparoscopic radical prostatectomy, Dr. Zeif provided a quantifiable metric for defining the learning curve—a critical advance for training surgeons and improving patient outcomes. This work bridges the gap between surgical technique and biochemical recurrence, offering a rigorous framework for evaluating procedural success. Although his citation count reflects a focused, high-impact niche, his research directly addresses a pressing clinical need: standardizing outcome measures in minimally invasive prostate surgery. Dr. Zeif’s contributions underscore the importance of integrating sensitive biomarkers into surgical assessment, influencing both urology practice and residency training. His approach remains a reference point for studies on surgical learning curves and postoperative monitoring in prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Ultrasensitive Prostate Specific Antigen Assay Following Laparoscopic Radical Prostatectomy – An Outcome Measure for Defining the Learning Curve
9 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Queen Elizabeth Hospital Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago